Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.020
-0.020 (-1.92%)
At close: Apr 21, 2026, 4:00 PM EDT
1.000
-0.020 (-1.96%)
Pre-market: Apr 22, 2026, 4:36 AM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $29.87 million as of April 22, 2026. Its market cap has increased by 42.62% in one year.
Market Cap
29.87M
Enterprise Value
26.03M
1-Year Change
42.62%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $29.87M, a decrease of -82.68%. That is a compound annual growth rate of -28.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 29.87M | 176.69% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABVC BioPharma | 31.38M |
| CEL-SCI | 30.83M |
| IGC Pharma | 30.53M |
| Dyadic International | 30.48M |
| Lantern Pharma | 30.04M |
| Tvardi Therapeutics | 29.55M |
| Skye Bioscience | 28.98M |
| BriaCell Therapeutics | 28.79M |